At SEMA, we believe every person has the right to make informed decisions about their body and future. We listen to the needs of local communities and work through strong partnerships with like-minded countries and organizations to create accessible sexual and reproductive healthcare (SRH) markets for all.
Increasing equitable access to sexual and reproductive health (SRH) products is critical to saving lives, promoting gender equality, and advancing communities.
SEMA has recently completed three new product assessments on Hormonal IUD, injectables, and medical abortion using our Healthy Markets Framework. These summary findings and recommendations can be reviewed here.